Skip to content
healthcare.dev

Repaglinide

NDC 57237-158, Repaglinide, tablet, from Rising Pharma Holdings, Inc..

Product NDC
57237-158
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203820
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-158 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE1 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
57237-158-0157237015801100 TABLET in 1 BOTTLE (57237-158-01)
57237-158-0557237015805500 TABLET in 1 BOTTLE (57237-158-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7673e22-0dbb-4395-ad60-943d249203a1
  • NADAC price for package 57237015801

    GET /v1/drugs/nadac/57237015801

Use it

Look up 57237-158 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-158 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.